Asia Pacific Stem Cell Therapy Market

Home Healthcare And Pharmaceutical Asia Pacific Stem Cell Therapy Market

Asia Pacific Stem Cell Therapy Market, By Type (Autologous, Allogeneic); By Cell Source (Adipose Tissue-derived, MSC, Bone Marrow, Placenta/Umbilical Cord); By Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological); By End User (Hospitals & Clinics, Academic & Research Institutes); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Published Date: January 2024
Report ID: BWC24064
Available Format: PDF
Page:

Report Overview

Growing prevalence of chronic diseases, increasing investments in research and development, rising awareness about stem cell therapy, and supportive government initiatives are key driving factors propelling the growth of the Asia Pacific Stem Cell Therapy Market during the forecast period between 2024 and 2030.

Asia Pacific Stem Cell Therapy Market – Industry Trends & Forecast Report, 2030

Asia Pacific Stem Cell Therapy Market size was estimated at USD 2.76 billion in 2023. During the forecast period between 2024 and 2029, the size of Asia Pacific Stem Cell Therapy Market is projected to grow at a CAGR of 10.48% reaching a value of USD 5.02 billion by 2030. The Asia Pacific Stem Cell Therapy Market is primarily driven by increasing investments in research and development of stem cell therapies for the treatment of rising prevalence of chronic diseases and growing awareness about the therapeutic potential of stem cells. Advancements in healthcare infrastructure, a surge in government initiatives, and the expanding elderly population contribute to market growth. Additionally, collaborations between research institutions and pharmaceutical companies, coupled with favorable regulatory frameworks, propel the adoption of stem cell therapies. The region's robust biotechnology sector and the pursuit of innovative treatment options further stimulate market expansion, fostering a conducive environment for advancements in stem cell therapy across diverse medical applications.

Asia Pacific Stem Cell Therapy Market

Stem Cell Therapy – Overview

Stem cell therapy involves using undifferentiated cells to treat or prevent diseases. These versatile cells have the unique ability to develop into various specialized cell types, promoting tissue repair and regeneration. Derived from embryos, adult tissues, or induced pluripotent stem cells, they offer promising potential for treating conditions like heart disease, neurological disorders, and injuries. Stem cell therapy aims to harness the body's natural healing abilities, advancing medical interventions by replacing damaged cells and tissues. While research is ongoing, ethical considerations and regulatory challenges underscore the need for careful exploration and application of this groundbreaking medical approach.

Asia Pacific Stem Cell Therapy Market

Growth Drivers

Escalating Chronic Disease Cases

The relentless surge in chronic diseases across Asia Pacific spurs the increasing need for innovative stem cell therapies. As the region grapples with an increasing burden of ailments, stem cell therapy emerges as a beacon of hope. With its potential to revolutionize treatment modalities, the Asia Pacific Stem Cell Therapy Market witnesses unprecedented growth, offering a lifeline to patients and transforming the healthcare landscape.

Challenges

Soaring Costs Could Deny Access to Stem Cell Therapies for Large Population across Asia Pacific

The Asia Pacific Stem Cell Therapy Market faces a critical challenge due to the high cost of stem cell therapy. The exorbitant costs associated with innovative medical treatment create a significant barrier to access. Affordability becomes a major concern, limiting the widespread adoption of stem cell therapy and hindering its potential impact on healthcare outcomes in the region. The financial restraint raises questions about equitable healthcare access and underscores the need for measures to address the soaring costs.

Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market

On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. In response to this global health crisis, researchers have been actively pursuing innovative cures and treatments. Recent years have demonstrated the efficacy of stem cell therapy in treating respiratory conditions, particularly COVID-19. The official international registry for clinical trials has recorded at least 10 projects focused on utilizing mesenchymal stem cells to treat patients with coronavirus pneumonia. The surge in research and clinical trials has led to an increased demand for stem cell therapy, consequently boosting the sales of stem cell therapy treatments.

Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market

Escalating geopolitical tensions in the Asia Pacific region have significant repercussions on the Stem Cell Therapy Market. Heightened uncertainties disrupt supply chains, hampering research and development efforts. For instance, territorial disputes involving China and its neighbors have led to economic uncertainties impacting investment in the sector. Additionally, the Russia-Ukraine war exacerbates challenges, with potential disruptions in the supply of raw materials and increased market volatility. The Asia Pacific Stem Cell Therapy Market faces a daunting landscape, grappling with geopolitical intricacies that threaten research continuity, collaboration, and investment flow, ultimately impeding the market's growth and innovation.

Asia Pacific Stem Cell Therapy Market

Segmental Coverage

Asia Pacific Stem Cell Therapy Market – By Type

Based on type, Asia Pacific Stem Cell Therapy Market is divided into Autologous and Allogeneic segments. Autologous stem cell therapy involves using a patient's cells for treatment, offering personalized and efficient solutions. The segment's prominence reflects the region's growing focus on personalized medicine and the potential for enhanced therapeutic outcomes through patient-specific treatments. Allogeneic stem cell therapy, which uses cells from a donor, also contributes to the market, catering to specific medical needs. However, the dominance of the autologous segment underscores the demand for tailored healthcare solutions in the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Cell Source

By cell source, Asia Pacific Stem Cell Therapy Market is divided into Adipose Tissue-Derived, MSC, Bone Marrow, and Placenta/Umbilical Cord segments. The mesenchymal stem cells (MSC) segment is the largest cell source in the Asia Pacific Stem Cell Therapy Market. MSCs have gained prominence due to their versatility in differentiation and therapeutic applications, contributing significantly to the region's stem cell therapy market. With widespread research and clinical applications, MSCs stand out as the leading segment, reflecting their pivotal role in advancing regenerative medicine across diverse medical fields in the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Application

Based on application, Asia Pacific Stem Cell Therapy Market is divided into Musculoskeletal, Wounds, Surgeries, Cardiovascular, and Neurological segments. Musculoskeletal application dominates the market, reflecting a significant focus on addressing orthopedic and musculoskeletal disorders through stem cell therapies. The segment underscores the region's emphasis on enhancing treatments for conditions related to bones, joints, and muscles, contributing to advancements in regenerative medicine and healthcare. The growing demand for innovative solutions in musculoskeletal applications signals a noteworthy trend in the Asia Pacific Stem Cell Therapy Market, positioning it as a key player in the global landscape.

Asia Pacific Stem Cell Therapy Market Share

Asia Pacific Stem Cell Therapy Market – By End user

By end user, Asia Pacific Stem Cell Therapy Market is divided into Hospitals & Clinics, and Academic & Research Institutes segments. The hospitals & clinics segment stands out as the larger segment, reflecting the significant adoption of stem cell therapy in medical settings. The dominance is attributed to the increasing awareness and acceptance of stem cell treatments for various medical conditions, emphasizing the pivotal role of healthcare institutions in driving the growth of stem cell therapy across the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Country

Based on country, Asia Pacific Stem Cell Therapy Market is divided into China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and Rest of APAC. China stands out as the largest segment, showcasing significant growth and dominance in stem cell therapy. The country's robust research initiatives, increasing healthcare investments, and a rapidly aging population contribute to its prominence in advancing stem cell technologies and applications. China's leadership in the market highlights its pivotal role in shaping the overall landscape of stem cell therapy in the Asia Pacific region.

Competitive Landscape

Major players in the Asia Pacific Stem Cell Therapy Market include Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, MEDIPOST Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, Mesoblast Ltd. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Stem Cell Therapy Market.

Recent Developments

In September 2020 - MEDIPOST initiated the Phase 2 clinical trial of CARTISTEM, an allogenic stem cell therapy product for knee osteoarthritis, in Japan.

Scope of Report

Attributes	Details
Years Considered	Historical Data – 2019–2023
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	Revenue in USD Billion
Market Coverage	China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC
Product/Service Segmentation	Type, Cell Source, Application, End User, Country
Key Players	Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, Medipost Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, Mesoblast Ltd.

By Type

Autologous
Allogeneic

By Cell Source

Adipose Tissue-Derived
MSC
Bone Marrow
Placenta/Umbilical Cord

By Application

Musculoskeletal
Wounds
Surgeries
Cardiovascular
Neurological

By End User

Hospitals & Clinics
Academic & Research Institutes

By Country

China
India
Japan
South Korea
Australia & New Zealand
Indonesia
Malaysia
Singapore
Vietnam
Rest of APAC

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Asia Pacific Stem Cell Therapy Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Rising prevalence of chronic diseases
    2. Growing awareness of stem cell therapy
  2. Restraints
    1. High cost of stem cell therapy
    2. Lack of regulation and standardization:
  3. Opportunities
    1. Development of personalized stem cell therapies:
    2. Expansion into new therapeutic areas:
  4. Challenges
    1. Limited clinical data:
3. Technological Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Asia Pacific Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
    1. Autologous
    2. Allogeneic
  2. By Cell Source
    1. Adipose Tissue-Derived
    2. MSC
    3. Bone Marrow
    4. Placenta/Umbilical Cord
  3. By Application
    1. Musculoskeletal
    2. Wounds
    3. Surgeries
    4. Cardiovascular
    5. Neurological
  4. By End User
    1. Hospitals & Clinics
    2. Academic & Research Institutes
  5. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia & New Zealand
    6. Indonesia
    7. Malaysia
    8. Singapore
    9. Vietnam
    10. Rest of APAC
China Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
India Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Japan Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
South Korea Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Australia & New Zealand Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Indonesia Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Malaysia Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Singapore Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Vietnam Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Rest of APAC Stem Cell Therapy Market Overview
1. Market Size & Forecast by Value & Volume, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Type
  2. By Cell Source
  3. By Application
  4. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Asia Pacific Stem Cell Therapy Company Market Share Analysis, 2023
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market
Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market
Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
1. Bristol Myers Squibb Company
2. Gilead Sciences Inc
3. JCR Pharmaceuticals Co Ltd,
4. Kolon TissueGene Inc
5. MEDIPOST Co Ltd,
6. Smith & Nephew Plc,
7. Vericel Corporation
8. Takeda Pharmaceutical Company Limited
9. Mesoblast Ltd
10. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumption & Limitation

*Financial information of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Figure 1 Asia Pacific Stem Cell Therapy Market Segmentation

Figure 2 Asia Pacific Stem Cell Therapy Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2023

Figure 4 Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 5 Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 6 Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 7 Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 8 Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 9 Asia Pacific Stem Cell Therapy Market Share, By Country, By Value, 2019–2030

Figure 10 China Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 11 China Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 12 China Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 13 China Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 14 China Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 15 India Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 16 India Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 17 India Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 18 India Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 19 India Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 20 Japan Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 21 Japan Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 22 Japan Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 23 Japan Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 24 Japan Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 25 South Korea Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 26 South Korea Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 27 South Korea Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 28 South Korea Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 29 South Korea Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 30 Australia & New Zealand Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 31 Australia & New Zealand Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 32 Australia & New Zealand Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 33 Australia & New Zealand Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 34 Australia & New Zealand Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 35 Indonesia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 36 Indonesia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 37 Indonesia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 38 Indonesia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 39 Indonesia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 40 Malaysia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 41 Malaysia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 42 Malaysia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 43 Malaysia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 44 Malaysia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 45 Singapore Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 46 Singapore Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 47 Singapore Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 48 Singapore Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 49 Singapore Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 50 Vietnam Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 51 Vietnam Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 52 Vietnam Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 53 Vietnam Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 54 Vietnam Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 55 Rest of Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 56 Rest of Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 57 Rest of Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 58 Rest of Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 59 Rest of Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

List of Tables

Table 1 Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 2 Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 3 Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 4 Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 5 Asia Pacific Stem Cell Therapy Market Size, By Country, By Value, 2019–2030

Table 6 China Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 7 China Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 8 China Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 9 China Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 10 India Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 11 India Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 12 India Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 13 India Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 14 Japan Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 15 Japan Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 16 Japan Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 17 Japan Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 18 South Korea Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 19 South Korea Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 20 South Korea Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 21 South Korea Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 22 Australia & New Zealand Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 23 Australia & New Zealand Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 24 Australia & New Zealand Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 25 Australia & New Zealand Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 26 Indonesia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 27 Indonesia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 28 Indonesia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 29 Indonesia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 30 Malaysia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 31 Malaysia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 32 Malaysia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 33 Malaysia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 34 Singapore Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 35 Singapore Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 36 Singapore Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 37 Singapore Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 38 Vietnam Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 39 Vietnam Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 40 Vietnam Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 41 Vietnam Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 42 Rest of Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 43 Rest of Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 44 Rest of Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 45 Rest of Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 46 Bristol Myers Squibb Company: Company Overview

Table 47 Bristol Myers Squibb Company Financial Overview

Table 48 Gilead Sciences Inc Company Overview

Table 49 Gilead Sciences Inc Financial Overview

Table 50 JCR Pharmaceuticals Co Ltd, Company Overview

Table 51 JCR Pharmaceuticals Co Ltd, Financial Overview

Table 52 Kolon TissueGene Inc Company Overview

Table 53 Kolon TissueGene Inc Financial Overview

Table 54 MEDIPOST Co Ltd, Company Overview

Table 55 MEDIPOST Co Ltd, Financial Overview

Table 56 Smith & Nephew Plc, Company Overview

Table 57 Smith & Nephew Plc, Financial Overview

Table 58 Vericel Corporation Company Overview

Table 59 Vericel Corporation Financial Overview

Table 60 Takeda Pharmaceutical Company Limited Company Overview

Table 61 Takeda Pharmaceutical Company Limited Financial Overview

Table 62 Mesoblast Ltd Company Overview

Table 63 Mesoblast Ltd Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current market size of Asia Pacific Stem Cell Therapy Market?

Ans: Asia Pacific Stem Cell Therapy Market size was estimated at USD 2.76 billion in 2023.

2. What is the expected CAGR of Asia Pacific Stem Cell Therapy Market during the forecast period?

Ans: Asia Pacific Stem Cell Therapy Market size is expected to grow at a CAGR of 10.48% during the forecast period between 2024 and 2030.

3. What is the forecast value of the Asia Pacific Stem Cell Therapy Market size by 2030?

Ans: Asia Pacific Stem Cell Therapy Market size is expected to reach a value of USD 5.02 billion by 2030.

4. What are the major factors driving the growth of Asia Pacific Stem Cell Therapy Market?

Ans: Major factors driving the growth of the Asia Pacific Stem Cell Therapy Market include the growing prevalence of chronic diseases, increasing investments in research and development, rising awareness about stem cell therapy, and supportive government initiatives.

5. Which country holds the highest market share in the Asia Pacific Stem Cell Therapy Market?

Ans: China accounts for the highest market share in the Asia Pacific Stem Cell Therapy Market.

6. Which end user holds the highest market share in the Asia Pacific Stem Cell Therapy Market?

Ans: The Hospitals & Clinics accounts for a higher market share in the Asia Pacific Stem Cell Therapy Market by end user.

7. Which is the leading segment in Asia Pacific Stem Cell Therapy Market by type?

Ans: The autologous segment accounts for a higher market share in the Asia Pacific Stem Cell Therapy Market by type.

8. Name the key players in Asia Pacific Stem Cell Therapy Market.

Ans: Key players in the Asia Pacific Stem Cell Therapy Market include Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, MEDIPOST Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, Mesoblast Ltd.

PLACE AN ORDER

SINGLE USER LICENSE
$ 3599
GROUP LICENSE
$ 4000
ENTERPRISE LICENSE
$ 4500
EXCEL DATA PACK
$ 2100

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Asia Pacific Stem Cell Therapy Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security